Research-Grade Stanozolol Compound Overview
REXOBOL 50 Pharmaceutical is a synthetic anabolic-androgenic steroid containing stanozolol in 50mg tablet formulation. This laboratory-grade compound enables researchers to investigate androgen receptor binding mechanisms, anabolic pathway modulation, and comparative steroid pharmacology studies. Stanozolol research demonstrates unique structural modifications that distinguish it from testosterone-derived compounds, making it valuable for examining selective androgenic effects in controlled laboratory environments. Academic institutions and certified research facilities utilise this compound to study protein synthesis pathways, nitrogen retention mechanisms, and tissue-selective anabolic responses in cellular models.
The pharmaceutical-grade formulation ensures consistent compound delivery for reproducible experimental protocols. Research applications extend across endocrinology, sports science, and molecular biology studies examining steroid receptor interactions. When sourced from Stroid UK Shop, researchers receive third-party verified compounds with comprehensive documentation supporting experimental validity.
Primary Laboratory Research Applications
Stanozolol research encompasses multiple scientific disciplines investigating anabolic steroid mechanisms. Cell culture studies examine receptor binding affinity, transcriptional activation, and downstream signaling cascades in muscle and bone tissue models. Comparative pharmacology research evaluates stanozolol’s unique 5α-reduced structure against other synthetic androgens, revealing distinct molecular interactions that influence tissue selectivity.
Metabolic research protocols investigate stanozolol’s effects on hepatic enzyme systems, lipid metabolism, and protein synthesis regulation. Studies examining collagen synthesis, wound healing, and bone density modulation utilise this compound alongside our extensive oral steroids stanozolol tablets collection. Advanced research combines stanozolol with SARMs to compare selective androgen receptor modulation patterns, while peptide co-administration studies examine synergistic effects on anabolic pathways.
Technical Specifications and Storage
| Parameter | Specification |
|---|---|
| Active Compound | Stanozolol |
| Strength | 50mg per tablet |
| CAS Registry | 10418-03-8 |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| Form | Oral tablets |
| Storage | Room temperature, dry environment |
| Stability | 24 months sealed |
Proper storage maintains compound integrity throughout extended research periods. Laboratory protocols require controlled temperature environments protecting against moisture, light exposure, and contamination. Documentation includes batch-specific certificates of analysis verifying purity, potency, and stability parameters essential for reproducible experimental outcomes.
Research Compliance and Safety
REXOBOL 50 Pharmaceutical is exclusively manufactured for in-vitro laboratory research and analytical testing purposes. This compound is not approved for human consumption, therapeutic use, or any application outside certified research facilities. Researchers must maintain proper laboratory safety protocols, disposal procedures, and documentation requirements when handling anabolic steroid compounds. All research applications require appropriate institutional oversight, safety training, and regulatory compliance within applicable jurisdictional frameworks governing controlled substance research.
